The management of Hodgkin disease in the young child
- 1 February 2003
- journal article
- review article
- Published by Ovid Technologies (Wolters Kluwer Health) in Current Opinion in Pediatrics
- Vol. 15 (1), 10-16
- https://doi.org/10.1097/00008480-200302000-00003
Abstract
Although childhood Hodgkin disease is sensitive to the treatment regimens devised for Hodgkin disease in adults, long-term toxicity is enhanced in the developing individual. As a result, there have been dual goals in the design of clinical trials for pediatric Hodgkin disease: 1) to reduce long-term organ injury; and 2) to increase efficacy. Radiation dose and field has been reduced by enhanced reliance on chemotherapy, thus limiting the risks of hypoplasia, hypothyroidism, secondary cancers, and valvular and atherosclerotic heart disease. Multiagent, chemotherapeutic regimens for children have been developed to avoid the risks of sterility, leukemia, and cardiopulmonary toxicity. Newer approaches advocate for early dose intensity to limit cumulative therapy using response-based paradigms. Targeting molecular mechanisms specific for the Reed-Sternberg cell may allow for less toxic and more efficacious treatments in the future.Keywords
This publication has 54 references indexed in Scilit:
- Interventional radiology techniques for the diagnosis of lymphoma or leukemiaPediatric Radiology, 2002
- Empowering patients to make informed treatment decisions based on tolerability, quality of life patient preference. A comparison of letrozole and anastrazole in a multicentre, randomised, single-blind cross over studyEuropean Journal Of Cancer, 2002
- Poor clinical outcome of patients with Hodgkin's Disease and elevated interleukin-10 serum levelsAnnals of Hematology, 2000
- Elevated pretreatment serum levels of Il-10 are associated with a poor prognosis in hodgkin's disease, the Milan Cancer Institute ExperienceMedical Oncology, 2000
- Interleukin-10 levels are often elevated in serum of adults with Hodgkin's disease and are associated with inferior failure-free survivalAnnals Of Oncology, 1999
- The Role of Radiation in the Management of Hodgkin's Disease: An UpdateCancer Investigation, 1999
- A Prognostic Score for Advanced Hodgkin's DiseaseNew England Journal of Medicine, 1998
- Lymphocyte predominant Hodgkin Disease: Clinico-pathologic features and results of treatment—The pediatric oncology group experienceMedical and Pediatric Oncology, 1997
- Alternating Drug Combinations in the Treatment of Advanced Hodgkin's DiseaseNew England Journal of Medicine, 1982
- Curability of Advanced Hodgkin's Disease with ChemotherapyAnnals of Internal Medicine, 1980